Charles Dominick

Charles Dominick is a Senior Research Associate at Century Therapeutics, Inc, specializing in the development of allogeneic CAR T-cell therapies and performing genetic modifications in gamma delta TiPSCs cell lines. Prior experience includes serving as an Undergraduate Research Fellow at the University of Scranton, where project leadership was demonstrated in studying hepatic steatosis effects on neurotransmitter catabolic enzymes in larval zebrafish, alongside roles as a Research Assistant and College Tutor. Additionally, Charles gained practical experience as a Protein Expression & Purification Intern at Amicus Therapeutics, focusing on cell line development and protein purification. Charles is currently pursuing a Master of Science in Biotechnology at The Johns Hopkins University, having previously earned a Bachelor's degree in Biochemistry Cellular and Molecular Biology from the University of Scranton.